Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Meta-analyses and adaptive group sequential designs in the clinical development process.

Christopher Jennison1, Bruce W Turnbull

  • 1Department of Mathematical Sciences, University of Bath, Bath, UK. cj@maths.bath.ac.uk

Journal of Biopharmaceutical Statistics
|July 19, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Type 2 diabetes risk alleles in peptidyl-glycine alpha-amidating monooxygenase influence GLP-1 levels and response to GLP-1 receptor agonists.

Genome medicine·2026
Same author

Clinical trials with interim analyses: standardizing terminology to increase clarity.

Trials·2025
Same author

Design and Analysis of Group Sequential Trials for Repeated Measurements When Pipeline Data Occurs: A Tutorial.

Statistics in medicine·2025
Same author

Type 2 Diabetes risk alleles in Peptidyl-glycine Alpha-amidating Monooxygenase influence GLP-1 levels and response to GLP-1 Receptor Agonists.

medRxiv : the preprint server for health sciences·2023
Same author

Discussion on "Adaptive enrichment designs with a continuous biomarker" by N. Stallard.

Biometrics·2022
Same author

Robust group sequential designs for trials with survival endpoints and delayed response.

Biometrical journal. Biometrische Zeitschrift·2021

Meta-analysis combines clinical trial data for robust treatment assessment. This approach integrates results from multiple studies, development programs, and adaptive trial designs to evaluate drug efficacy and safety effectively.

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Pharmaceutical Development

Background:

  • Clinical development involves sequential trials, with designs influenced by prior and concurrent studies.
  • Assessing treatment efficacy and safety requires integrating results from all relevant trials.

Purpose of the Study:

  • To explore meta-analysis techniques for combining data within clinical development.
  • To demonstrate applications in integrating Phase IIb and Phase III trials and analyzing adaptive group sequential designs.

Main Methods:

  • Application of meta-analysis to combine results from separate studies.
  • Utilizing meta-analysis for sequential studies within a development program.
  • Employing meta-analysis for stages within adaptive group sequential trials.

Related Experiment Videos

Main Results:

  • Meta-analysis provides a formal framework for combining diverse trial data.
  • Demonstrated seamless transition from Phase IIb to Phase III by combining trial results.
  • Showcased the use of combination tests in adaptive group sequential trial analysis.

Conclusions:

  • Meta-analysis is a valuable tool for synthesizing evidence throughout the clinical development process.
  • The presented methods facilitate robust treatment evaluation and informed decision-making.
  • Adaptive designs and meta-analysis enhance the efficiency and integrity of drug development.